81-OR: The Impact of Proinflammatory Cytokines on Human Pancreatic Islet Alternative Splicing Patterns

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 81-OR
Author(s):  
WENTING WU ◽  
FAROOQ SYED ◽  
EDWARD SIMPSON ◽  
CHIH-CHUN LEE ◽  
DECIO L. EIZIRIK ◽  
...  
2021 ◽  
Vol 10 (1) ◽  
Author(s):  
Dunhui Li ◽  
Craig Stewart McIntosh ◽  
Frank Louis Mastaglia ◽  
Steve Donald Wilton ◽  
May Thandar Aung-Htut

AbstractPrecursor messenger RNA (pre-mRNA) splicing is a fundamental step in eukaryotic gene expression that systematically removes non-coding regions (introns) and ligates coding regions (exons) into a continuous message (mature mRNA). This process is highly regulated and can be highly flexible through a process known as alternative splicing, which allows for several transcripts to arise from a single gene, thereby greatly increasing genetic plasticity and the diversity of proteome. Alternative splicing is particularly prevalent in neuronal cells, where the splicing patterns are continuously changing to maintain cellular homeostasis and promote neurogenesis, migration and synaptic function. The continuous changes in splicing patterns and a high demand on many cis- and trans-splicing factors contribute to the susceptibility of neuronal tissues to splicing defects. The resultant neurodegenerative diseases are a large group of disorders defined by a gradual loss of neurons and a progressive impairment in neuronal function. Several of the most common neurodegenerative diseases involve some form of splicing defect(s), such as Alzheimer’s disease, Parkinson’s disease and spinal muscular atrophy. Our growing understanding of RNA splicing has led to the explosion of research in the field of splice-switching antisense oligonucleotide therapeutics. Here we review our current understanding of the effects alternative splicing has on neuronal differentiation, neuronal migration, synaptic maturation and regulation, as well as the impact on neurodegenerative diseases. We will also review the current landscape of splice-switching antisense oligonucleotides as a therapeutic strategy for a number of common neurodegenerative disorders.


Diabetes ◽  
2021 ◽  
pp. db200847
Author(s):  
Wenting Wu ◽  
Farooq Syed ◽  
Edward Simpson ◽  
Chih-Chun Lee ◽  
Jing Liu ◽  
...  

2008 ◽  
Vol 17 (12) ◽  
pp. 1315-1322 ◽  
Author(s):  
Aditya Agrawal ◽  
Kurinchi Gurusamy ◽  
Steve Powis ◽  
Derek W. Gray ◽  
Barry Fuller ◽  
...  

Diabetologia ◽  
2005 ◽  
Vol 48 (8) ◽  
pp. 1523-1533 ◽  
Author(s):  
Domenico Bosco ◽  
Paolo Meda ◽  
Philippe Morel ◽  
David Matthey-Doret ◽  
Dorothée Caille ◽  
...  

2021 ◽  
Author(s):  
Carlos F Buen Abad Najar ◽  
Prakruthi Burra ◽  
Nir Yosef ◽  
Liana F Lareau

Alternative splicing shapes the transcriptome and contributes to each cell's unique identity, but single-cell RNA sequencing has struggled to capture the impact of alternative splicing. We previously showed that low recovery of mRNAs from single cells led to erroneous conclusions about the cell-to-cell variability of alternative splicing. Here, we present a method, Psix, to confidently identify splicing that changes across a landscape of single cells, using a probabilistic model that is robust against the data limitations of scRNA-seq. Its autocorrelation-inspired approach finds patterns of alternative splicing that correspond to patterns of cell identity, such as cell type or developmental stage, without the need for explicit cell clustering, labeling, or trajectory inference. Applying Psix to data that follow the trajectory of mouse brain development, we identify exons whose alternative splicing patterns cluster into modules of co-regulation. We show that the exons in these modules are enriched for binding by distinct neuronal splicing factors, and that their changes in splicing correspond to changes in expression of these splicing factors. Thus, Psix reveals cell-type-dependent splicing patterns and the wiring of the splicing regulatory networks that control them. Our new method will enable scRNA-seq analysis to go beyond transcription to understand the roles of post-transcriptional regulation in determining cell identity.


PLoS Genetics ◽  
2012 ◽  
Vol 8 (3) ◽  
pp. e1002552 ◽  
Author(s):  
Décio L. Eizirik ◽  
Michael Sammeth ◽  
Thomas Bouckenooghe ◽  
Guy Bottu ◽  
Giorgia Sisino ◽  
...  

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 2080-P
Author(s):  
STANISLAV RUBAKHIN ◽  
JONATHAN V. SWEEDLER

Sign in / Sign up

Export Citation Format

Share Document